Dupilumab

Common brands: Dupixent, Albuterol, Ventolin Hfa, Proair Digihaler, Proair Respiclick

Top reporter: Sanofi-Aventis U.S. Llc

Interleukin-4 Receptor alpha Antagonist [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]Proton Pump Inhibitor [EPC]
438,499
Total Reports
371,681
Serious Reports
1,972
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.45%)

Patient Demographics

Male
161,818
Female
252,872

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Dupilumab.

# Reaction Reports % of Total
1 PRURITUS 52,379
9.5%
2 DERMATITIS ATOPIC 41,045
7.4%
3 PRODUCT USE IN UNAPPROVED INDICATION 38,078
6.9%
4 RASH 35,570
6.4%
5 INJECTION SITE PAIN 32,857
5.9%
6 DRUG INEFFECTIVE 27,750
5.0%
7 ECZEMA 24,172
4.4%
8 PRODUCT DOSE OMISSION ISSUE 23,332
4.2%
9 DRY SKIN 23,316
4.2%
10 CONDITION AGGRAVATED 19,621
3.5%
11 ARTHRALGIA 17,651
3.2%
12 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17,346
3.1%
13 ASTHMA 14,715
2.7%
14 ACCIDENTAL EXPOSURE TO PRODUCT 13,305
2.4%
15 SKIN EXFOLIATION 13,299
2.4%
16 DYSPNOEA 12,782
2.3%
17 OFF LABEL USE 12,593
2.3%
18 ERYTHEMA 12,524
2.3%
19 DRY EYE 12,355
2.2%
20 INCORRECT DOSE ADMINISTERED 11,572
2.1%
21 EXPOSURE VIA SKIN CONTACT 11,430
2.1%
22 INJECTION SITE SWELLING 10,951
2.0%
23 PRODUCT USE ISSUE 10,648
1.9%
24 COUGH 10,199
1.8%
25 INJECTION SITE ERYTHEMA 10,065
1.8%
26 EYE PRURITUS 9,347
1.7%
27 PRODUCT DOSE OMISSION IN ERROR 9,015
1.6%
28 THERAPEUTIC RESPONSE DECREASED 8,708
1.6%
29 PAIN 8,699
1.6%
30 HEADACHE 8,540
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.